1093070-16-6
Chemical Structure
GRL0617
- CAS No.: 1093070-16-6
- Formula:C20H20N2O
- Molecular Weight:304.39
IUPAC Name: (R)-5-amino-2-methyl-N-(1-(naphthalen-1-yl)ethyl)benzamide
InChIKey: UVERBUNNCOKGNZ-CQSZACIVSA-N
SMILES: O=C(N[C@@H](C1=C2C=CC=CC2=CC=C1)C)C3=CC(N)=CC=C3C
Biological Activity: GRL0617 is a selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro), with an IC50 of 0.6 μM and a Ki value of 0.49 μM. GRL0617 also inhibits SARS-CoV with an EC50 of 14.5 μM. GRL0617 can be used for the research of severe acute respiratory syndrome[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GRL0617 | 99.49% | GRL0617 is a selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro), with an IC50 of 0.6 μM and a Ki value of 0.49 μM. GRL0617 also inhibits SARS-CoV with an EC50 of 14.5 μM. GRL0617 can be used for the research of severe acute respiratory syndrome. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords